First Page | Document Content | |
---|---|---|
![]() Date: 2012-01-16 13:52:49Pharmacology Synthes Adverse effect MedWatch Medical device Class I recall U.S. Securities and Exchange Commission Medicine Health Food and Drug Administration | Add to Reading List |
![]() | Referenz-Story DePuy Synthes Der neue Europa-Hauptsitz von DePuy Synthes ist ein moderner Neubau im solothurnischen Zuchwil: Hier beschäftigt das Medizinaltechnik-Unternehmen rund 500 Mitarbeitende in der Forschung undDocID: 1swf5 - View Document |
![]() | Abteilung Drehen Synthes Bettlach GmbHDocID: 1pXhR - View Document |
![]() | Abteilung Drehen Synthes Bettlach GmbHDocID: 1pFi2 - View Document |
![]() | Abteilung Drehen Synthes Bettlach GmbHDocID: 1p53u - View Document |
![]() | 27 JuneThis report has been issued for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of third parties regarding revenues, earnings and busineDocID: 1ovo8 - View Document |